Novel peptide dimers are provided that bind and activate the erythropoietin receptor (EPO-R) or otherwise act as an EPO agonist. The novel compounds have a first peptide chain R1 and a second peptide chain R2, wherein R1 and R2 may be the same or different, and are linked through a linking moiety. R1...http://www.google.fr/patents/US7459522?utm_source=gb-gplus-shareBrevet US7459522 - Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use
Peptide dimers as agonists of the erythropoietin (EPO) receptor, and ...
